Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation
- 1 July 2005
- journal article
- review article
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 9 (25), 1-142
- https://doi.org/10.3310/hta9250
Abstract
Health Technology Assessment Volume: 9, Issue: 25, Published in July 2005Keywords
Funding Information
- Health Technology Assessment Programme (03/01/01)